Narrative review of the assessment of the uterus and ovaries in infertile women The diagnostic value of a baseline assessment of the uterus and ovaries with imaging or surgery versus pelvic examination The diagnostic value of TVUS, HSG, hysteroscopy, HyCoSy, SHG and MRI in detecting uterine, endometrial and/or ovarian pathology The prognostic value of assessment of the uterus and ovaries with imaging or diagnostic hysteroscopy on clinical pregnancy and live birth rates (became pregnant unassisted or through ART) BACKGROUND: This review focuses on the initial presentation of women who suspect that they are infertile, and how best to assess the anatomy of their uterus and ovaries in order to investigate the cause of their infertility, and potentially improve desired fertility outcomes. This review was undertaken as part of a World Health Organization initiative to assess the evidence available to address guidance for the diagnosis and treatment of infertility within a global context. Providing access to care for infertile women will help to ease the psycho-social burdens, such as ostracization, intimate partner violence and other negative consequences of being involuntarily childless or unable to become pregnant despite desiring a biological child or children.
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Introduction
The purpose of assessing the uterus and ovaries of infertile women is to identify pathology, which may influence the chance of natural conception and the success or outcome of all therapies including ART, and to potentially offer treatment of these pathologies with the aim of increasing a woman's chances of becoming pregnant.
Common uterine and ovarian abnormalities associated with infertility include leiomyoma, adhesions, polyps, cervical stenosis, ovarian cysts and congenital abnormalities such as septate or bicornuate uterus (Wallach, 1972; Honore,1997) .
Ultrasonography (US), preferably transvaginal ultrasound (TVUS), is used to screen for possible ovarian, endometrial or uterine cavity abnormalities in the work-up of women with fertility problems. This evaluation can be augmented with hysterosalpingography (HSG), saline infusion/gel instillation sonography and diagnostic hysteroscopy (Bosteels et al., 2015) . Diagnostic hysteroscopy is generally considered as the gold standard procedure for the assessment of the uterine cavity because it enables direct visualization and provides an opportunity for concurrent treatment of intrauterine pathology (Golan et al., 1996; Bettocchi et al., 2004) . Hystero-contrast salpingography (HyCoSy) is a procedure that allows ultrasound imaging of the uterine cavity and assessment of Fallopian tube patency by instilling an aqueous contrast medium through the cervix. MRI (also known as NMR) is another imaging modality, which can assess both the uterus and ovaries.
Recommendations from national guidelines on the investigation of uterine abnormalities for women presenting with fertility problems vary. The National Institute for Health and Care Excellence (NICE) does not have a recommendation regarding the routine assessment of uterine abnormalities but recommends that 'women should not be offered hysteroscopy on its own as part of the initial investigation unless clinically indicated because the effectiveness of surgical treatment of uterine abnormalities in improving pregnancy rates has not been established' (NICE, 2013) . Similarly, the Society of Obstetricians and Gynaecologists of Canada states that 'it is unclear whether all women with infertility should have the integrity of their endometrial cavity evaluated' (Carranza-Mamane, 2015) .
Conversely, the American Society for Reproductive Medicine (ASRM) states that although 'abnormalities of uterine anatomy or function are an uncommon cause of infertility in women, they should be excluded and this can be accomplished using HSG, US, hysterocontrast sonography (HyCoSy) or hysteroscopy' (Practice Committee of American Society for Reproductive, 2012) .
Throughout this document, we refer to women as opposed to couples. It is assumed that the male partner or an identified male sperm donor will undergo diagnostic testing in parallel to these initial investigations of the woman.
Methods

Evidence synthesis methodology
The methodology used to support the provision of global recommendations is outlined in the WHO Handbook for Guideline Development (2014) (http:// apps.who.int/iris/bitstream/10665/75146/1/9789241548441_eng.pdf).
The overall prioritized question posed for the development of a global guideline was 'should women with infertility have a baseline assessment of their uterus and ovaries and what is the best way of achieving this?' This question was further distilled into three separate searchable PICO (P-patient, problem or population; I-intervention; C-comparison, control or comparator; O-outcome.) components:
-The diagnostic value of a baseline assessment of the uterus and ovaries with imaging or surgery versus pelvic examination. -The diagnostic value of TVUS, HSG, hysteroscopy, HyCoSy, saline sonohysterography and MRI in detecting uterine, endometrial and/or ovarian pathology. -The prognostic value of assessment of the uterus and ovaries with imaging or diagnostic hysteroscopy on clinical pregnancy and live birth rates (became pregnant unassisted or through ART).
The PICO question was delineated in the following manner: Participants were defined as infertile women of reproductive age with or without clinical suspicion of uterine and/or ovarian pathology. The interventions were TVUS, HSG, hysteroscopy, HyCoSy, saline sonohysterography (SHG) and MRI. The comparison was pelvic examination or any one of the aforementioned investigations against another. The outcomes were diagnosis of infertility in association with uterine, endometrial or adnexal (ovarian) pathology and clinical pregnancy and live birth rates. The study design was systematic review with qualitative synthesis of the data. We did not specifically address tubal pathology, as this was undertaken by a different evidence-synthesis team.
Inclusion criteria
For the assessment of the diagnostic capacity of imaging or surgery to assess the uterus and ovaries versus pelvic examination, and for comparing the diagnostic advantages of each of these tests, systematic reviews of cross sectional or cohort studies with a consistently applied. A reference standard and blinding were sought, and if these were not available, we sought individual cross sectional or cohort studies with a consistently applied reference standard and blinding. Studies without a consistently applied reference test were excluded. For prognostic studies, systematic reviews, RCTs, prospective and retrospective cohort studies reporting the unassisted clinical pregnancy rate and or livebirth rate following any of the above imaging or surgical procedures, with or without an abnormal result, with or without treatment, among infertile women trying without assistance for a baby or undergoing fertility treatment were included. Studies assessing non-clinical outcomes were excluded.
Search
We searched The Cochrane CENTRAL Register of Studies, The Cochrane Menstrual Disorders and Subfertility Group's Specialised Register, MEDLINE, Embase, CINAHL, PubMed, and The Virtual Health Library on the 28 August 2014. The searches were created by an Information Specialist and were designed to find studies, (RCTs, cohort, cross-sectional or systematic reviews), that investigated the prognostic or diagnostic use of imaging for gynacecological issues associated with infertility. These strategies were not limited by date or language. We also checked citations on the Web of Science and the reference lists of all the relevant studies and systematic reviews. In order to ensure that the evidence was current, the searches were rerun, in all the above-mentioned databases, on 6 June 2016. Search strategies were supplied to the WHO.
Data extraction
We extracted and tabulated data on the characteristics, quality and results of each eligible study and combined the findings in a narrative synthesis.
Risk of bias assessment
Risk of bias was assessed for each study included in the review. For systematic reviews, the Cochrane risk of bias tool was used. For assessing the methodological quality of systematic reviews, AMSTAR (assessment of the methodological quality of systematic reviews) was used. For cohort studies, the Newcastle Ottawa assessment scale was used. For diagnostic accuracy tests, QUADAS (quality assessment tool for diagnostic accuracy studies) was used and for studies assessing prognostic factors, QUIPS (quality in prognostic studies) was used. Information from risk of bias assessment was used when applying GRADE (grading of recommendations, assessment, development and evaluation) to assess the quality of the evidence.
Development of recommendations
Discussion of the data with resultant consensus recommendations for best practice were accomplished during the consensus committee meeting in Geneva, October 2015. Best practice can be defined in this context as clinical implementation of the available evidence (Perleth et al., 2001 ). An independent expert review process on the work of our group and the consensus outcomes was conducted during 2016.
Summary of outcomes
The specific recommendations formulated on the baseline assessment of the uterus and ovaries in infertile women are included in the text below along with an assessment of the quality of the supporting evidence based on our evidence synthesis summarized below.
Narrative review of the assessment of the uterus and ovaries in infertile women Third, what is the prognostic value of assessment of the uterus and ovaries with imaging or surgery, with or without ensuing treatment, on clinical pregnancy and live birth rates (became pregnant unassisted or through ART)? These questions are addressed through a narrative review of the evidence that we used to support our recommendations.
The search returned 3968 publications in total. About 63 full text articles were retrieved and checked for relevance. A further 10 studies were found through citation-checking and hand-searching of the references of articles retrieved. About 54 were excluded (e.g. because they did not report outcomes of interest or were included in the latest systematic review). Screening of titles, abstracts and full papers and data extraction were carried out by the first author (S.C.A.) using piloted data extraction forms. Nineteen studies were selected as being the best evidence available. Figure 2 , the PRISMA diagram, demonstrates the flow of studies throughout the review.
Four studies were found which addressed the diagnostic value of a baseline assessment of the uterus and ovaries with imaging or surgery versus pelvic examination. Two were prospective diagnostic studies and two were retrospective cross-sectional studies (Frederick et al., 1991; Nezhat et al., 1994; Reuss et al., 1996; Hudelist et al., 2011) .
Ten studies were found which addressed the diagnostic value of TVUS, HSG, hysteroscopy, HyCoSy, SHG and MRI in detecting uterine, endometrial and/or ovarian pathology: one systematic review, eight prospective diagnostic studies and one retrospective crosssectional study (Golan et al., 1996; Hamilton et al., 1998; Aboulghar et al., 2011; Bingol et al., 2011; La Sala et al., 2011; Bocca et al., 2012; Niknejadi et al., 2012; Bahadur et al., 2013; Ludwin et al., 2013; Seshadri et al., 2015) .
Three systematic reviews and two RCTs were found which assessed the prognostic value of assessment of the uterus and ovaries with imaging or surgery, with or without ensuing treatment, on clinical pregnancy and live birth rates (Lindborg et al., 2009; Bosteels et al., 2010 Bosteels et al., , 2015 Di Spiezio Sardo et al., 2016; Smit et al., 2016) .
Most of the studies were conducted in high-income countries in Europe, the UK and the USA. Other studies were conducted in the Middle East and India. The four systematic reviews included studies from low-, middle-and high-income countries.
All women in the four included studies that assess the diagnostic value of a baseline assessment of the uterus and ovaries with imaging or Figure 1 Flow diagram of the assessment of uterine and ovarian anatomy of women first presenting with infertility. TV, transvaginal; HyCoSy, hystero-contrast salpingography.
surgery, versus pelvic examination experienced symptoms of gynaecological pathology (Frederick et al., 1991; Nezhat et al., 1994; Reuss et al., 1996; Hudelist et al., 2011) . Only one study (Hudelist et al., 2011) included a small proportion of women with infertility (n = 20, 15.5%). The remaining three studies did not specifically include women with infertility and included a mixture of pre-and post-menopausal women. Separate data were not available for women with infertility. All five studies assessing the diagnostic value of TVUS versus SHG included women with primary and secondary infertility, and one (La Sala et al., 2011) also included women with abnormal uterine bleeding. Three studies included women with suspected uterine pathology detected on initial ultrasound or HSG (Aboulghar et al., 2011; Bingol et al., 2011; La Sala et al., 2011) . The study by Ludwin included women specifically with suspected uterine anomalies (e.g. bicornuate and unicornuate uteri) (Ludwin et al., 2013) .
Both studies assessing the diagnostic value of TVUS versus hysteroscopy involved women with primary and secondary infertility who had no symptoms of uterine pathology (Niknejadi et al., 2012; Bahadur et al., 2013) .
All women within the systematic review assessing the diagnostic value of SHG versus hysteroscopy were infertile and undergoing IVF or ICSI (Seshadri et al., 2015) .
The one study that assessed the diagnostic value of HSG versus hysteroscopy involved 464 infertile women being referred for diagnostic hysteroscopy (Golan et al., 1996) . The majority of participants (94%) were sent for hysteroscopy after suspicious findings were discovered on HSG, and the remaining participants were referred for hysteroscopy without suspicious findings.
The study that assessed the diagnostic value of 3D TVUS versus HSG included women who had been referred with the finding of uterine anomalies on prior two-dimensional (2D) TVUS or MRI (Bocca et al., 2012) .
Two systematic reviews by the same lead author (Bosteels et al., 2010 (Bosteels et al., , 2015 were found which assessed the prognostic value of hysteroscopy prior to ART. Bosteels et al. (2010) included infertile women without other gynaecological symptoms, with polyps, fibroids, septate uterus and intrauterine adhesions or women treated by IVF or IUI. Bosteels et al. (2015) included women with unexplained infertility, with or without symptoms of pelvic pathology, or women undergoing ART. One RCT (Smit et al., 2016) was found which randomized infertile women with a normal TVUS undergoing their first cycle of IVF to receive hysteroscopy with immediate treatment of any pathology discovered or no hysteroscopy. One RCT was found which assessed the prognostic value of HyCoSy in women with unexplained infertility trying without assistance for a baby (Lindborg et al., 2009 ).
The diagnostic value of a baseline assessment of the uterus and ovaries with imaging or surgery versus pelvic examination
Four studies were found which addressed this question. Two were prospective diagnostic studies (Frederick et al., 1991; Hudelist et al., 2011) , and the other two were retrospective cross-sectional studies (Nezhat et al., 1994; Reuss et al., 1996) . Frederick et al. (1991) included women aged 16-67 years who presented with symptoms of pelvic pathology such as pain, abnormal bleeding or dyspareunia. Hudelist et al. (2011) included premenopausal women with symptoms suggestive of endometriosis, a small proportion of whom (n = 20, 15.5%) were women with fertility problems. The two retrospective studies included women with symptoms of gynaecological pathology (endometriosis, fibroids, etc.). None of the women included in these two studies were reported as suffering from infertility, and Nezhat et al. (1994) included pre-and post-menopausal women. Three studies compared standard 2D TVUS plus pelvic examination versus pelvic examination. One study compared TVUS alone versus pelvic examination alone, with the TVUS operators blinded to the pelvic examination findings. All women in all studies underwent a surgical diagnostic procedure (laparoscopy or laparotomy) as the reference procedure. No studies were found which compared pelvic examination with any other test. Frederick et al. found that, compared to pelvic examination alone, pelvic examination plus adjunctive TVUS was more sensitive (65.7% versus 93.8%), more specific (98.4% versus 92.5%) and more accurate (97.7% versus 84.9%) in detecting a range of pelvic pathology. The chart review (Reuss et al.,1996) found that, compared to pelvic examination alone, pelvic examination plus adjunctive TVUS was less likely to give a false negative result in women with fibroids (36% versus 70.5%). The other chart review (Nezhat et al.,1994) found concordance of 65% between pelvic examination alone and pelvic examination plus adjunctive TVUS, with false negative rates in women with endometriosis of 47% versus 41%, respectively. Adjunctive TVUS was more informative when the uterine surface and ovaries were involved (false negative rate of 89% versus 11%). Hudelist et al. (2011) compared pelvic examination alone versus TVUS alone for diagnosing deep infiltrating endometriosis and reported their accuracy for diagnosing endometriosis in various sites including the ovaries (87% versus 96%), uterosacral ligaments (73% versus 90%), pouch of Douglas (89% versus 96%), vagina (96% versus 96%), rectovaginal space (97% versus 99%), urinary bladder (98% versus 97%) and rectosigmoid (84% versus 97%). Overall these findings suggest that TVUS is a valuable adjunct to pelvic examination for the definitive diagnosis of pelvic pathology.
The diagnostic value of TVUS, HSG, hysteroscopy, HyCoSy, SHG and MRI in detecting uterine, endometrial and/or ovarian pathology Ten studies were found which addressed this question: one systematic review (Seshadri et al., 2015) , eight prospective diagnostic studies (Golan et al., 1996; Hamilton et al., 1998; Aboulghar et al., 2011; Bingol et al., 2011; La Sala et al., 2011; Bocca et al., 2012; Bahadur et al., 2013; Ludwin et al., 2013) and one retrospective crosssectional study (Niknejadi et al., 2012) .
TVUS versus SHG
Five prospective diagnostic studies were found which administered both TVUS and SHG (Hamilton et al., 1998; Aboulghar et al., 2011; Bingol et al., 2011; La Sala et al., 2011; Ludwin et al., 2013) . All studies included women with primary and secondary infertility, and La Sala et al. (2011) also included women with abnormal uterine bleeding. Three studies included women with suspected uterine pathology detected on initial ultrasound or HSG (Aboulghar et al., 2011; Bingol et al., 2011; La Sala et al., 2011) The study by Ludwin et al. (2013) included women specifically with suspected uterine anomalies (e.g. bicornuate or unicornuate uteri). Three studies were based in European countries and the remaining two studies were undertaken in Middle Eastern countries. Three (Aboulghar et al., 2011; Bingol et al., 2011; La Sala et al., 2011) used hysteroscopy as a 'gold-standard' reference test in all women, while in Hamilton et al. (1998) and Ludwin et al. (2013) only women with a suspected abnormality had a hysteroscopy. The studies by Aboulghar et al. (2011) and Ludwin et al. (2013) used both 2D and three-dimensional (3D) TVUS and SHG.
Although all the studies administered both tests in all women, only two (Hamilton et al., 1998; Bingol et al., 2011) reported rates of concordance with hysteroscopy and in these studies only women with suspected pathology underwent hysteroscopy. Hamilton et al. (1998) reported that concordance rates for diagnosis of any intrauterine lesion were 52.6% in the TVUS group and 65% in the SHG group. Bingol et al. (2011) reported an overall sensitivity of TVUS and SHG for detecting endometrial hyperplasia, polypoidal lesions and submucous myoma of 0.93 (95% CI 0.89-0.96) and 0.98 (95% CI 0.96-0.99), respectively. Specificity for TVUS and SHG was 0.60 (95% CI 0.49-0.71) and 0.83 (95% CI 0.71-91), respectively. In Aboulghar et al. (2011) , in which all women underwent the reference standard, accuracy for detecting any uterine cavity abnormality was 77.2% with 2D TVUS, 84.8% with 3D TVUS, 92.4% with 2D SHG and 93.6% with 3D SHG; for polyps, the respective accuracies for 2D TVUS, 3D TVUS, 2D SHG and 3D SHG were 89.61, 92.21, 98 .70 and 100%; for adhesions, they were 90.79, 92.11, 94.74 and 93.42%, and for Mullerian abnormalities they were 96.1, 100, 98.70 and 100%. La Sala et al. (2011) reported that the sensitivities and specificities of TVUS and SHG for polyps (52.6%, 95.7% versus 86.8%, 92.8%, respectively), submucous myomas (20%, 96.9% versus 90%, 99%) and adhesions (0%, 0% versus 75%, 100%). In Ludwin et al. (2013) , in which women had a hysteroscopy if an anomaly was identified on other tests, the accuracy for detecting a common congenital uterine abnormality was 90.6% with expert 2D TVUS, 97.4% with 3D TVUS, 94% with 2D SHG and 100% with 3D SHG.
Findings were somewhat inconsistent, but both TVUS and SHG appeared to have acceptable accuracy for detecting polyps, adhesions, Mullerian abnormalities and congenital uterine abnormalities. When drafting recommendations, context experts in our group took into account that SHG is a more invasive test than TVUS.
TVUS versus hysteroscopy
One prospective diagnostic study and one retrospective crosssectional study were found which answered this question (Niknejadi et al., 2012; Bahadur et al., 2013) . Both studies included women with primary and secondary infertility, who were asymptomatic for uterine pathology. Both studies took place in a low-or middle-income country (India and Iran) and included 1513 women. Hysteroscopy was the reference test.
The study by Bahadur et al. (2013) reported that the sensitivity, specificity and diagnostic accuracy with 95% CI of diagnosing uterine anomalies using TVUS versus hysteroscopy was 41.3% (34.4-48.5%), 94.6% (92.7-96.1%) and 83.3% (80.7-85.7%), respectively. The accuracy was 83.3% (80.7-85.7). The false negative rate was 59% and the false positive rate was 33%. The retrospective study by Niknejadi et al. (2012) had similar specificity and positive predictive value (PPV) (82 and 84%) to Bahadur et al. (2013) , but higher sensitivity (79%).
TVUS has lower sensitivity for detecting intrauterine pathology in comparison to hysteroscopy, particularly for adhesions, submucous fibroids and congenital malformations in women presenting for ART. However, TVUS does have high specificity and diagnostic accuracy and is a non-invasive investigation.
SHG versus hysteroscopy
One systematic review of 20 studies with 1645 procedures (Seshadri et al., 2015) compared SHG with hysteroscopy as the gold standard reference test. All women were infertile and undergoing IVF.
The sensitivity, specificity, positive likelihood ratio and negative likelihood ratios with 95% CI for SHG versus hysteroscopy for all intrauterine pathologies are as follows: 0.88 (0.85-0.90), 0.94 (0.93-0.96), 20.93 (9.06-48.34) and 0.15 (0.10-0.22) . SHG has good accuracy in the detection of all intrauterine abnormalities (sensitivity on y-axis, 1 minus specificity on x-axis: area under summary receiver operating curve = 0.97 ± 0.01). A limitation of the review includes the heterogeneity amongst the included studies.
HSG versus hysteroscopy
One prospective diagnostic study was found which addressed this comparison (Golan et al., 1996) . It compared HSG using an aqueous contrast media with outpatient hysteroscopy under local anaesthesia. A total of 464 women were included and the study took place in Israel. Hysteroscopy was used as the reference test. The sensitivity, specificity, PPV and negative predictive value of HSG compared to hysteroscopy were 98, 15, 45 and 95%, respectively. Fifty-three percentage of HSG examinations detected a 'filling defect' and 56% of HSG examinations detected a 'wall irregularity', which were subsequently found by hysteroscopy to be normal uterine cavities. In comparison to hysteroscopy, HSG has low PPV and low specificity for intrauterine pathology.
3D TVUS versus HSG
One prospective diagnostic study, based in the USA, which included 101 women, addressed the comparison of 3D TVUS versus HSG (Bocca et al., 2012) . All women had been referred with the finding of uterine anomalies on prior 2D TVUS or MRI. All women underwent 3D TVUS and HSG, with hysteroscopy and laparoscopy as the gold standard reference tests. This study compared the detection rate of uterine anomalies between 3D TVUS and HSG and found that 3D TVUS provides similar or better accuracy than HSG. The study also estimated the cost of diagnosis and treatment of 20 septate uteri by both imaging modalities and found that 3D TVUS was significantly less expensive than hysteroscopy and laparoscopy (US$ 13 620 versus $18 000-42 000, respectively). No adverse events were reported with TVUS and six minor ones with HSG (pelvic discomfort, spotting, etc.). 3D TVUS provides visualization and evaluation of the uterine cavity with similar or better accuracy to HSG with lower cost and morbidity.
The prognostic value of assessment of the uterus and ovaries with imaging or diagnostic hysteroscopy on clinical pregnancy and live birth rates (became pregnant unassisted or through ART) Three systematic reviews (Bosteels et al., 2010 (Bosteels et al., , 2015 Di Spiezio Sardo et al., 2016) and one RCT (Smit et al., 2016) were found which assessed the prognostic value of hysteroscopy prior to ART. One RCT was found which assessed the prognostic value of HyCoSy in women with unexplained infertility, who were trying without assistance to become pregnant (Lindborg et al., 2009) . No studies which examined the prognostic value of other imaging modalities were found. Comparators were hysteroscopy without subsequent treatment, or no hysteroscopy.
Hysteroscopy Bosteels et al. (2010) included RCTs and controlled studies on the hysteroscopic treatment of endometrial polyps, submucous fibroids, septate uterus or intrauterine adhesions in subfertile women without other gynaecological symptoms. Couples aged 40 years or over were excluded, as were heterosexual couples with severe male factor infertility, or women previously known to have severe tubal infertility and suspected anovulation. Bosteels et al. (2010) found that hysteroscopic removal of endometrial polyps with a mean diameter of 16 mm detected by ultrasound doubles the clinical pregnancy rate when compared to diagnostic hysteroscopy and polyp biopsy in patients undergoing IUI starting 3 months after the surgical intervention (Risk ratio (RR) 2.3; 95% CI 1.6-3.2). In women with one fibroid <4 cm, there was a marginally significant benefit from myomectomy when compared to expectant management (RR 1.9; 95% CI 1.0-3.7). Metroplasty for septate uterus resulted in fewer pregnancies in women with infertility when compared to those with recurrent pregnancy loss (RR 0.7; 95% CI 0.5-0.9). Hysteroscopy in the cycle preceding the subsequent IVF attempt nearly doubles the clinical pregnancy rate in women with at least two failed IVF attempts compared with starting IVF immediately (RR 1.7; 95% CI 1.5-2.0). The evidence within this review was not graded for quality by the authors. A Cochrane review (Bosteels et al., 2015) included two RCTs which examined the impact of hysteroscopic myomectomy and hysteroscopic polypectomy on clinical pregnancy and live birth rates in infertile heterosexual couples with unexplained infertility or undergoing ART. It concluded that a large clinical benefit with hysteroscopic myomectomy cannot be excluded: the evidence suggests that 39% of women (95% CI 21-58%) in a heterosexual relationship will achieve a clinical pregnancy following hysteroscopic removal of the fibroids (odds ratio (OR) 2.44, 95% CI 0.97-6.17, P = 0.06, 94 women, very low quality evidence) compared to 21% of similar women without hysteroscopic surgery.
There is no evidence of a difference between the groups for the outcome of miscarriage (OR 0.58, 95% CI 0.12-2.85, P = 0.50, 30 clinical pregnancies in 94 women, very low quality evidence).
Regarding endometrial polyps, hysteroscopic removal of polyps prior to IUI increased the chance of a clinical pregnancy compared to diagnostic hysteroscopy and polyp biopsy. Thus, if 28% of women achieve a clinical pregnancy with a diagnostic hysteroscopy, the evidence suggests that 63% of women (95% CI 50-76%) will achieve a clinical pregnancy after the hysteroscopic removal of the endometrial polyps (OR 4.41, 95% CI 2.45-7.96, P < 0.00001, 204 women, moderate quality evidence).
Di Spiezio Sardo et al. (2016) undertook a systematic review to assess the efficacy of diagnostic and operative hysteroscopy in improving the live birth rate of infertile women, with and without intrauterine abnormalities, at any stage of the fertility work-up. The review included two RCTs of women undergoing their first attempt at IVF/ICSI, and four RCTs of women with one or more failed IVF/ICSI cycles and one RCT included a mixture of both first and subsequent cycles. Two RCTs included infertile women affected by uterine fibroids and endometrial polyps, who were undergoing IUI or expectant management with a heterosexual partner. Risk of bias was assessed and the overall quality of evidence was assessed using the GRADE approach.
In infertile women without intrauterine abnormalities undergoing any number of IVF/ISCI attempt, there was very low quality evidence that hysteroscopy increased the live birth rate when compared with no hysteroscopy (RR 1.48, 95% CI 1.20-1.81) and moderate quality evidence that it increased clinical pregnancy rate (RR 1.45, 95% CI 1.26-1.67). Comparing operative hysteroscopy versus diagnostic hysteroscopy for intrauterine abnormalities in infertile women with already diagnosed polyps or fibroids, there was low quality evidence that operative hysteroscopy increases clinical pregnancy rate (RR 2.13, 95% CI 1.56-2.92).
An RCT of routine hysteroscopy prior to the first IVF treatment cycle investigated if live birth rates were improved (Smit et al., 2016) . Women with a normal baseline TVUS scan were randomized to undergo hysteroscopy with subsequent treatment of any pathology found, or no hysteroscopy (n = 750). A total of 209 (57%) of 369 women eligible for assessment in the hysteroscopy group and 200 (54%) of 373 in the immediate IVF group had a live birth from a pregnancy during the trial period (RR 1.06, 95% CI 0.93-1.20; P = 0.41). One woman (<1%) in the hysteroscopy group developed endometritis after hysteroscopy.
The findings of these studies do not support the routine use of hysteroscopy as a first-line procedure in the initial assessment of all infertile women. Studies involved women with pelvic pain or a history giving rise to a suspicion of pelvic pathology. Some studies did not involve subfertile/infertile women. 3 Significant heterogeneity between studies. Some included women with pelvic pain, others with suspicion of pelvic pathology. Some studies included pre-menopausal women, whereas others included pre and post-menopausal women.
4 Bosteels et al. (2015) has many unknown and high risk of bias domains. Risk of bias assessment not performed on included studies in Bosteels et al. (2010) . 5 High heterogeneity amongst the RCTs that examine hysteroscopy in women with failed cycles of IVF with low numbers of participants and broad CIs. Single RCT that examines hysteroscopy in women undergoing their first cycle of IVF with a normal scan. 6 Time interval between tests was sometimes lengthy.
7 PICO (P-patient, problem or population, I-intervention, C-comparison, control or comparator, O-outcome) differed significantly between studies-some were women with known pre-existing pathology, others with none. Hystero-contrast salpingography An RCT included 334 heterosexual couples with fertility problems trying without assistance to become pregnant (Lindborg et al., 2009) . These couples were randomized to undergo HyCoSy or no HyCoSy. The clinical pregnancy rate was 29.2% in the HyCoSy group and 26.5% in the non-HyCoSy group, the difference being 2.7% (95% CI −6.9-12.3%, P = 0.63). Live birth rates were 22.6 and 20.5% and the corresponding miscarriage rates were 5.4 and 4.8%, respectively. There was one ectopic pregnancy in each group. Time to pregnancy was not significantly different between the two groups (P = 0.25). We considered that these findings do not support use of HyCoSy as a therapeutic procedure.
Discussion
All of the conclusions of this review have had the quality of the evidence assessed using GRADE (Table 1) . Tables II-V demonstrate the various tools used for risk of bias for each included paper.
Diagnostic value of a baseline assessment of the uterus and ovaries with imaging or surgery, versus pelvic examination Pelvic examination with TVUS is more accurate in detecting pelvic pathology than pelvic examination alone in women with symptoms suspicious of pelvic pathology. In particular, TVUS is better at detecting ovarian pathology. n/a n/a n/a n/a n/a n/a Yes n/a Yes n/a
Were withdrawals from the study explained?
Yes n/a n/a n/a n/a n/a yes n/a n/a n/a
HSG versus hysteroscopy
In comparison to hysteroscopy, HSG has low PPV and low specificity for intrauterine pathology.
3D TVUS versus HSG
3D TVUS provides evaluation of the uterine cavity with similar or better accuracy than HSG, with lower cost and morbidity.
MRI versus any other test
There are no data to draw conclusions on this comparison.
Prognostic value of assessment of the uterus and ovaries with imaging or surgery, with or without ensuing treatment, on clinical pregnancy and live birth rates (became pregnant unassisted or through ART)
Hysteroscopy − There is scant good quality evidence on the prognostic value of assessment of the uterus and ovaries with hysteroscopy, with or without hysteroscopic surgery, in infertile women with polyps, fibroids, septate uterus or intrauterine adhesions. − In infertile women with a normal TVUS scheduled for their first cycle of IVF, routine hysteroscopy does not improve outcome.
Hystero-contrast salpingography
HyCoSy does not increase the chance of pregnancy or shorten the time to pregnancy and should not be offered as a therapeutic procedure.
Draft recommendations
-TVUS should be offered to all infertile women with symptoms or signs of anatomic pelvic pathology. -TVUS is a well-tolerated, cost-effective, accurate test for the exclusion of uterine and ovarian pathology for infertile women with and without symptoms of pelvic pathology; however, there is no evidence for its routine use. -Hysteroscopy should be offered if intrauterine pathology is suspected by the TVUS. − Hysteroscopy should not be routinely offered to infertile women who have a normal TVUS. − In women who have a normal TVUS and are undergoing IVF, hysteroscopy does not improve the outcome.
Opinion based good practice points
-Providers of fertility care should confirm that all infertile women have had a recent pelvic examination, recent cervical screening and well-woman screening in line with local guidelines. -HyCoSy in infertile women does not improve clinical pregnancy rates with expectant management in heterosexual couples and should not be offered as a therapeutic procedure.
Conclusion
Based on the evidence reviewed, we conclude that TVUS should be offered to all infertile women with symptoms or signs of anatomic pelvic pathology. There is no evidence that routinely offering an ultrasound to women without symptoms of pelvic pathology is helpful. Hysteroscopy should be offered if intrauterine pathology is suspected by TVUS but should not be routinely offered to infertile women who have normal TVUS findings. Evidence suggests that in women who have normal TVUS findings and are undergoing IVF, hysteroscopy does not improve the outcome. Based on the expert opinion of our evidence team, providers of fertility care should confirm that all infertile women have had a recent pelvic examination, a recent cervical smear and well-woman screening in line with relevant guidelines. Moreover, HyCoSy should not be offered to infertile women as a therapeutic procedure as there is no evidence that it improves unassisted pregnancy rates. Our conclusions apply to infertile women whether or not they are undergoing fertility treatment.
We did not consider in our review specific diagnostic subgroups of endometrial and uterine pathology, such as endometrial polyps, submucous myoma and adhesions, as we anticipated that there would be insufficient data to reach any meaningful conclusions owing to lack of statistical power. This may limit the applicability of our findings. Most of the findings of this review are based on low or very low quality evidence, according to GRADE Working Group criteria. A low grading indicates that further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate, while a very low grade indicates that any estimate of effect is very uncertain. This review has highlighted the scarcity of high quality evidence to support the use of most methods of assessing for anatomical pathology of the uterus and ovaries. Future studies should particularly focus on the diagnostic and prognostic value of hysteroscopy, MRI, 3D ultrasound, HSG and SHG. Diagnostic studies should be prospective, and methods for assessing the uterus and ovaries should be assessed against a 'gold standard' test, such as hysteroscopy or laparoscopy. Those undertaking both the primary test and the 'gold standard' should be blinded to the results of each. Prognostic studies of methods for assessing the uterus and ovaries should ideally be RCTs, combined where possible into systematic reviews. designed and coordinated the global consensus and evidencesynthesis teams.
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